Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Annual Meeting Talks

Sign in to view content

Sign in

Expert Panel: Faricimab and Aflibercept 8 mg in AMD

  • John T. Thompson, MD
  • Andrew A. Moshfeghi, MD, MBA, FASRS
  • Manjot K Gill, MD, FASRS
  • Christina Y Weng, MD, MBA, FASRS
  • Ferhina S Ali, MD, MPH
  • Ian Pearce, MB ChB BSc FRCOPHTH
  • Video
  • Published 2024

Related

  • Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy

    Milam A. Brantley, MD, PhD

    On Demand Cases, Courses, and Papers

    2019

  • Retinal Vascular Disease Symposium

    Annual Meeting Talks

    2020

  • Treatment of CRVO: SCORE2 Sub-analysis

    Michael S. Ip, MD

    Updates from the Field

    2019

Category: AMD-Neovascular

  • Anti-VEGF
  • Retinal Vascular Disease
  • Choroidal Neovascularization
  • Polypoidal Choroidal Vasculopathy
  • outcomes
  • randomized clinical trial
  • randomized controlled trial
  • Faricimab
  • wet macular degeneration
  • real world
  • anti-vascular endothelial growth factor
  • aflibercept 8 mg
  • extended treatment
  • interval
  • extended treatment interval
  • high-dose aflibercept
  • FARWIDE nAMD

See more

  • Annual Meeting Talks
  • John T. Thompson, MD
  • Andrew A. Moshfeghi, MD, MBA, FASRS
  • Manjot K Gill, MD, FASRS
  • Christina Y Weng, MD, MBA, FASRS
  • Ferhina S Ali, MD, MPH
  • Ian Pearce, MB ChB BSc FRCOPHTH
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.